|
SYF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.023200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.795800E-01 |
| Normal-vs-Stage2 |
2.021800E-01 |
| Normal-vs-Stage3 |
3.091000E-01 |
| Normal-vs-Stage4 |
5.114400E-02 |
| Stage1-vs-Stage2 |
2.966000E-02 |
| Stage1-vs-Stage3 |
9.055800E-01 |
| Stage1-vs-Stage4 |
2.096000E-01 |
| Stage2-vs-Stage3 |
3.707900E-02 |
| Stage2-vs-Stage4 |
6.503800E-03 |
| Stage3-vs-Stage4 |
3.248800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.728800E-01 |
| Normal-vs-AfricanAmerican |
1.689630E-01 |
| Normal-vs-Asian |
1.454170E-01 |
| Caucasian-vs-AfricanAmerican |
3.719800E-01 |
| Caucasian-vs-Asian |
5.040400E-01 |
| AfricanAmerican-vs-Asian |
7.077600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.384600E-01 |
| Normal-vs-Female |
3.975000E-01 |
| Male-vs-Female |
5.412600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.471600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.519010E-01 |
| Normal-vs-Age(61-80Yrs) |
6.875600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.091800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.749000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.223760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.611200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.996300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.384010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.460200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.042600E-01 |
| Classical-VS-Follicular |
1.231540E-04 |
| Classical-VS-Other |
5.406600E-01 |
| Classical-VS-Normal |
5.441900E-02 |
| Tall-VS-Follicular |
1.461920E-02 |
| Tall-VS-Other |
5.085200E-01 |
| Tall-VS-Normal |
2.403400E-01 |
| Follicular-VS-Other |
5.144400E-02 |
| Follicular-VS-Normal |
7.682400E-02 |
| Other-VS-Normal |
3.179000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.940000E-01 |
| Normal-vs-N1 |
2.052200E-01 |
| N0-vs-N1 |
9.301800E-02 |
|
|
